- ADHA, University of Sydney team up for cardiology care
- NUS scientists design blood test to detect Alzheimer's
- Daiichi Sankyo, GE Healthcare sign marketing deal for four imaging agents
- PREMIA, AmoyDx to establish Asia Cancer Clinical Genomic Network
- LabCorp, Mount Sinai HS to develop AI-enabled pathology CoE
- Thunes Appoints New Chief Financial Officer
- World's first medical & donation coin disclosed on BW.com
- GENFIT, Terns Pharma announce $228M strategic partnership
- NATHEALTH & the Netherlands explore bilateral collaborations in Digital Health
- Singapore HSA approves Vosevi to treat Chronic Hepatitis C Virus
- Surgical Theater received approval to market SNAP and SRP Systems
- Gilead, Carna Biosciences announce R&D collaboration
- Pulse healthcare app enters Malaysia
- FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy
-
Specials | 07 June 2019 | Opinion
The video technology changing the healthcare industry
According to a report presented at last year’s World Economic Forum on ASEAN, a healthcare spending cris...Read more
Singapore | 06 June 2019 | Opinion
"We have an active M&A pipeline to accelerate growth"
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, first established its presen...Read more
-
China | 25 June 2019 | News
GENFIT, Terns Pharma announce $228M strategic partnership
GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therap...Read more
-
Singapore | 26 June 2019 | News
NUS scientists design blood test to detect Alzheimer's
Doctors may one day be able to diagnose Alzheimer’s disease (AD), the most common cause of severe dement...Read more
-
World | 17 June 2019 | News
FDA approves new cochlear implant with easier access to MRI
Cochlear Limited, the global leader in implantable hearing solutions announced the U.S. Food and Drug Administ...Read more
-
World | 24 June 2019 | News
Agilent invests$185M in new facility to develop Oligos
Agilent Technologies Inc. has announced the opening of a production facility in Colorado that more than double...Read more
ASIA-PACIFIC: MODEST RISE IN HEALTHCARE DEALS
Healthcare private equity tends to be less vulnerable to downturns than other sectors, so it expects demand for assets in Asia-Pacific to increase over the coming years. Buyout funds will invest more in growth-stage assets such as Chinese pharma. And as companies explore ways to increase access to healthcare, emerging trends, such as digital healthcare solutions, should gain steam in China, India and other countries. Investors will continue to seek deals in the provider and medtech sectors, and explore creative ways to deploy capital, such as public-toprivate takeovers. Baker McKenzie Global Transactions Forecast predicts a modest rise of 7 per cent in deals to $331 billion in 2019, as a number of cross-border and domestic megadeals are set to close.
